Page last updated: 2024-11-04

sulfamethoxazole and Carcinoma, Renal Cell

sulfamethoxazole has been researched along with Carcinoma, Renal Cell in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sebastian, K1
Ott, H1
Zwadlo-Klarwasser, G1
Skazik-Voogt, C1
Marquardt, Y1
Czaja, K1
Merk, HF1
Baron, JM1

Other Studies

1 other study available for sulfamethoxazole and Carcinoma, Renal Cell

ArticleYear
Evaluation of the sensitizing potential of antibiotics in vitro using the human cell lines THP-1 and MUTZ-LC and primary monocyte-derived dendritic cells.
    Toxicology and applied pharmacology, 2012, Aug-01, Volume: 262, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Carboxylic Ester Hydrolases; Carcinoma, Renal Cell; Carrier Prote

2012